{
    "symbol": "AXSM",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-07 13:29:05",
    "content": " These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our investigational agents; our clinical and non-clinical plans; our plans to present or report additional data; the anticipated conduct and the source of future clinical trials; regulatory plans; future research and development plans; our commercial plans regarding Sunosi, Auvelity and our pipeline products; revenue projections; and possible intended use of cash and investments. Your line is now live. Thanks for taking our questions. Thanks for the question. Your line is now live. Thanks for the question. Your line is now live. Thanks for taking our questions. Thanks for the question. Your line is now live. Your line is now live. Thanks for the question. Your line is now live. Your line is now live. Thanks for taking our questions. Thanks for the question. Your line is now live. Your line is now live. Your line is now live. Thanks for the question. Your line is now live. Your line is now live. Thanks for the question. Your line is now live."
}